Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction

Rungroj Krittayaphong(Siriraj Hospital), Unchalee Permsuwan(Chiang Mai University)

International Journal of Cardiology

August 13, 2020

10.1016/j.ijcard.2020.08.017

Cited by 54

Related Papers

Stroke prevention in atrial fibrillation—An Asian stroke perspective

|Heart Rhythm|2013|153

A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation.

|PubMed|2003|132

Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: A randomized placebo-controlled study

|American Heart Journal|2002|131

Heart rate variability in patients with Brugada syndrome in Thailand

|European Heart Journal|2003|63

Thai Registry in Acute Coronary Syndrome (TRACS)--an extension of Thai Acute Coronary Syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year.

|PubMed|2012|62